Effect of the angiotensin receptor-neprilysin inhibitor sacubitril/valsartan on the pharmacokinetics and pharmacodynamics of a single dose of furosemide-Reference-Cited by-同舟云学术

Effect of the angiotensin receptor-neprilysin inhibitor sacubitril/valsartan on the pharmacokinetics and pharmacodynamics of a single dose of furosemide

Published:2018-02-20 Issue:5 Volume:84 Page:926-936
ISSN:0306-5251
Container-title:British Journal of Clinical Pharmacology
language:en
Short-container-title:Br J Clin Pharmacol

Author:

Ayalasomayajula Surya¹,Schuehly Uwe²,Pal Parasar³,Chen Fabian⁴,Zhou Wei¹,Sunkara Gangadhar¹,Langenickel Thomas H.²^ORCID

Affiliation:

1. Novartis Institutes for BioMedical Research; East Hanover NJ USA

2. Translational Medicine, Novartis Institutes for BioMedical Research; Novartis Pharma AG; Basel Switzerland

3. Biostatistical Sciences; Novartis Healthcare Pvt. Ltd.; Hyderabad India

4. Clinical Development; Novartis Pharmaceuticals; East Hanover NJ USA

Funder

Novartis Pharmaceuticals Corporation

Novartis Pharma AG, Basel, Switzerland

Publisher

Wiley

Subject

Pharmacology (medical),Pharmacology

Link

http://onlinelibrary.wiley.com/wol1/doi/10.1111/bcp.13505/fullpdf

Reference30 articles.

1. Effect of enalapril on survival in patients with reduced left ventricular ejection fractions and congestive heart failure;The SOLVD Investigators;N Engl J Med,1991

2. Spotlight on valsartan-sacubitril fixed-dose combination for heart failure: the evidence to date;Vilela-Martin;Drug Des Devel Ther,2016

3. Angiotensin-neprilysin inhibition versus enalapril in heart failure;McMurray;N Engl J Med,2014

4. Angiotensin receptor neprilysin inhibition compared with enalapril on the risk of clinical progression in surviving patients with heart failure;Packer;Circulation,2015

5. Dicarboxylic acid dipeptide neutral endopeptidase inhibitors;Ksander;J Med Chem,1995

Cited by 15 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. First‐in‐Human Study to Assess the Safety, Pharmacokinetics, and Pharmacodynamics of BMS‐986308: A Renal Outer Medullary Potassium Channel Inhibitor;Clinical Pharmacology & Therapeutics;2024-09-02

2. The Interplay of Comorbidities in Chronic Heart Failure: Challenges and Solutions;Current Cardiology Reviews;2024-05

3. Bioanalytical HPLC method with fluorescence detector for determination of Entresto™ when co-administered with ibuprofen and fexofenadine: a pharmacokinetic study;RSC Advances;2024

4. Effect of sacubitril/valsartan on brain natriuretic peptide level and prognosis of acute cerebral infarction;PLOS ONE;2023-09-21

5. Critical Analysis of the Effects of SGLT2 Inhibitors on Renal Tubular Sodium, Water and Chloride Homeostasis and Their Role in Influencing Heart Failure Outcomes;Circulation;2023-07-25